About PainChek
PainChek is a publicly listed company based in Sydney (Australia) founded in 2010. Pain assessment app using facial recognition is provided for caregivers. Its chief executive, as recorded, is Philip Daffas. Its website painchek.com draws about 12 thousand monthly visits. PainChek offers products and services including PainChek App and PainChek Analytics. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
PainChek was established in 2010 in Sydney, Australia, within the healthcare technology sector. A mobile application is developed for pain assessment and monitoring through facial recognition. The tool assists caregivers and patients with cognitive impairments, such as dementia, in reporting pain accurately. Treatment compliance and effectiveness are tracked by caregivers via the apps features. Operations focus on enabling reliable pain management in clinical and home settings.
- Headquarters Sydney, Australia
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website painchek.com
- Social LinkedIn X Facebook YouTube
- Annual Revenue$2.58 M (USD)11.45as on Jun 30, 2026
- Net Profit-$6.16 M (USD)-16.46as on Jun 30, 2026
- EBITDA-$6.82 M (USD)-8.83as on Jun 30, 2026
- Investors
Products & Services of PainChek
PainChek offers a comprehensive portfolio of products and services, including PainChek App and PainChek Analytics.
Mobile app for AI-driven pain evaluations in care settings
Portal providing insights for optimizing pain management
Apps and channels of PainChek
PainChek publishes 1 mobile app with over 5K+ downloads; its YouTube channel PainChek has 176 subscribers and 30 videos.
Videos from PainChek
The most watched videos on PainChek's YouTube channel, PainChek (176 subscribers). Click a video to play it here.
More on PainChek.
Funding Insights of PainChek
- Total Rounds 3
- First Round $5M
(Apr 2019)
- Investors Count 1
All 3 funding rounds of PainChek with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | Post-IPO | – | – | ||
| Aug 2020 | $7.16M | Post-IPO | – | – | – |
| Apr 2019 | $5M | Grant | – | – | – |
1 investors in total: 1 institutional.
Investors in PainChek
PainChek has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gwent Regional Partnership Board.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health and wellbeing outcomes are improved for Gwent residents. | gwentrpb.wales | Pontypool, Wales |
Investor details for PainChek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PainChek
27 people are tracked at PainChek (7 in leadership, 5 in board & advisors, 15 in team).
| Name | Role | Group |
|---|---|---|
Philip Daffas | CEO & Managing Director | Leadership |
David Allsopp | Head of Business Development ANZ | Leadership |
Andrew Hoggan | Head of Operations | Leadership |
Scott Robertson | Chief Technology Officer | Leadership |
Jeff Hughes | Chief Scientific Officer | Leadership |
Iain McAdam | Chief Financial Officer | Leadership |
Tandeep Gill Mrpharms | Head Of Business Development Uk&i | Leadership |
Adam Davey | Director | Board & advisors |
Sally McDow | Secretary | Board & advisors |
Ross Harricks | Director | Board & advisors |
John Murray | Chairman | Board & advisors |
Cynthia Payne | Non Executive Board Member | Board & advisors |
Dawn Kerr | Senior Clinical Specialist | Team |
Thomas Morten (Assoc Cipd | Training And Implementation Manager | Team |
Kreshnik Hoti | Senior Research Scientist | Team |
Tandeep Gill | Senior Business Development Manager | Team |
Khush Najran | UK Operations Manager | Team |
Sara Crabtree | Account Manager | Team |
Amran Sanghera | Senior Business Development Manager | Team |
Caleb Ng | Quality Assurance/ Regulatory Affairs Manager | Team |
7 more people are available in the full profile.
Complete people profiles for PainChek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PainChek
PainChek is a publicly listed company on the ASX with ticker symbol PCK in Australia, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date01 May 2012
- Listed onASX: PCK
- Listed entityPAINCHEK LTD
- Exchange sectorTechnology services
Timeline of PainChek
4 dated milestones of PainChek across 12 years, from founding to its latest funding, stage changes and deals.
- Founded PainChek is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $5.0M.
- Funding Latest funding round, Post-IPO,.
Web traffic of PainChek
The website of PainChek (painchek.com) receives about 11.8K visits a month.
- Monthly visits11.8K
▼ 26.6% vs previous month
Websites whose visitors overlap most with PainChek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
australianageingagenda.com.au | australianageingagenda.com.au | 100% | #1,638,391 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Painchek
Complete news archive for PainChek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PainChek
PainChek was founded in 2010 and raised its 1st funding round 9 years after it was founded.
PainChek is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Philip Daffas is the CEO of PainChek, as recorded in our data.
Annual revenue of PainChek is $2.58M as on Jun 30, 2026.
PainChek was established in 2010 in Sydney, Australia, within the healthcare technology sector. A mobile application is developed for pain assessment and monitoring through facial recognition. The tool assists caregivers and patients with cognitive impairments, such as dementia, in reporting pain accurately. Treatment compliance and effectiveness are tracked by caregivers via the apps features. Operations focus on enabling reliable pain management in clinical and home settings.
PainChek offers PainChek App and PainChek Analytics.
Yes, PainChek is publicly traded on ASX under the ticker symbol PCK.
PainChek has 1 investor. Key investors include Gwent Regional Partnership Board.
Yes. PainChek publishes PainChek Enterprise, with over 5,000 downloads.